Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Perion Network | PERI | Nov 22, 2024 | 8.52 | +1.07 |
Perma-Fix Environmental Services | PESI | Nov 22, 2024 | 14.42 | -2.63 |
Perma-Pipe International | PPIH | Nov 22, 2024 | 15.35 | -0.32 |
Permian Basin Royalty Trust | PBT | Nov 22, 2024 | 13.86 | +0.73 |
Permian Resources | PR | Nov 22, 2024 | 16.21 | +1.38 |
Permianville Royalty Trust Unit | PVL | Nov 22, 2024 | 1.55 | +0.65 |
PermRock Royalty Trust Unit | PRT | Nov 22, 2024 | 4.02 | +0.81 |
Perpetua Resources | PPTA | Nov 22, 2024 | 9.88 | +0.82 |
Perrigo | PRGO | Nov 22, 2024 | 28.07 | +3.66 |
Personalis | PSNL | Nov 22, 2024 | 3.47 | +2.66 |
Perspective Therapeutics | CATX | Nov 22, 2024 | 3.47 | +15.67 |
Petco Health And Wellness | WOOF | Nov 22, 2024 | 4.17 | 0.00 |
PetIQ A | PETQ | Nov 22, 2024 | 30.98 | 0.00 |
PetMed Express | PETS | Nov 22, 2024 | 4.78 | +3.02 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Nov 22, 2024 | 14.90 | +5.30 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Nov 22, 2024 | 13.59 | +4.30 |
Petros Pharmaceuticals | PTPI | Nov 22, 2024 | 0.27 | +5.02 |
Pfizer | PFE | Nov 22, 2024 | 25.65 | +2.07 |
Pgim Global High Yield Fund | GHY | Nov 22, 2024 | 12.90 | +1.65 |
Pgim High Yield Bond Fund | ISD | Nov 22, 2024 | 13.88 | +0.07 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Nov 22, 2024 | 16.60 | +0.18 |
Pharmaceutical ETF Market Vectors | PPH | Nov 22, 2024 | 88.58 | +0.73 |
PharmaCyte Biotech | PMCB | Nov 22, 2024 | 1.70 | -2.86 |
Pharming Group ADR | PHAR | Nov 22, 2024 | 7.53 | -2.96 |
Pharvaris | PHVS | Nov 22, 2024 | 22.29 | +5.94 |
Phathom Pharmaceuticals | PHAT | Nov 22, 2024 | 9.34 | -1.16 |
PhenixFIN | PFX | Nov 22, 2024 | 46.28 | -0.47 |
Pheton | PTHL | Nov 22, 2024 | 4.68 | 0.00 |
Phibro Animal Health A | PAHC | Nov 22, 2024 | 23.74 | -0.08 |
Philip Morris | PM | Nov 22, 2024 | 129.99 | -0.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.